Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology and Health Care & Life Sciences Sectors with the addition of Brian Tomkins as a partner in the Mechanical & Electromechanical Technologies Practice Group. Tomkins, who joins Foley’s New York office, is the latest testament to the firm’s strategic expansion on the East Coast and its offerings across key practices and sectors.
Tomkins’ practice encompasses all areas of intellectual property, including global IP strategy, due diligence, clearance, litigation, and transactional work such as mergers and acquisitions, licensing, development agreements, and joint ventures. He advises clients across a wide range of industries, with a particular focus on medical devices, biotechnology, pharmaceuticals, software, blockchain, and financial services. Tomkins also provides strategic counseling on the acquisition, protection, and commercialization of new technologies and product lines.
“Brian brings a wealth of experience managing complex IP transactions, especially in high-growth industries such as medical devices, biotechnology, and emerging technologies,” said Matthew Martin, chair of the Mechanical & Electromechanical Technologies Practice Group. “His background in counseling clients on both high-level transactional work and IP litigation strengthens our team’s ability to deliver tailored and effective solutions to address our clients’ diverse IP needs.”
Tomkins has extensive experience managing global IP portfolios and providing due diligence support for M&A and other transactions involving IP rights. He advises clients on strategies to address third-party IP risks, including clearance opinions, IP challenges, and licensing agreements. Tomkins also has experience in patent, trademark, copyright, and trade secret litigation, as well as pharmaceutical patent litigation under the Hatch-Waxman Act.
“We continue to invest in expanding our New York office and East Coast presence, and the addition of Brian is a key part of our strategy to strengthen our capabilities in the region,” said Anne Sekel, managing partner of Foley’s New York office. “His experience in managing significant IP transactions not only enhances our capabilities but also complements our M&A and Fund Formation & Investment Management teams here in New York, providing us with even greater depth to address the growing transactional and IP needs of our clients.”
“This move is a natural progression in my practice, and joining Foley was an easy decision,” said Tomkins. “The firm’s strong bench, extensive resources, and solid reputation will provide the support I need to continue addressing complex legal issues for our clients. I look forward to collaborating with a nationwide team, particularly in the life sciences and medical device sectors, to deliver comprehensive legal solutions to Foley’s diverse and expansive clientele.”
폴리 앤 라드너 LLP 소개
폴리 앤 라드너 LLP는 에너지, 의료 및 생명과학, 혁신 기술, 제조 부문의 접점에 서 있는 유수한 로펌입니다. 우리는 법률을 넘어 고객이 직면한 끊임없이 진화하는 요구에 초점을 맞추고 창의적이고 실용적이며 효과적인 솔루션을 제공하기 위해 신뢰할 수 있는 비즈니스 자문가로서 활동합니다. 전 세계 26개 사무소의 1,100명의 변호사가 기업 자문부터 지적 재산권 업무 및 소송 지원에 이르기까지 모든 분야에서 협력하여 고객에게 모든 요구 사항에 대한 원팀 솔루션을 제공합니다. 거의 2세기 동안, Foley는 최고 수준의 혁신적인 법률 서비스를 제공하고 직원, 회사, 고객, 지역사회에 대한 책임을 다하기 위해 노력해 왔습니다.
